bms-986393
Showing 1 - 1 of 1
Multiple Myeloma Trial in Boston (BMS-986393, Alnuctamab, Mezigdomide)
Not yet recruiting
- Multiple Myeloma
- BMS-986393
- +3 more
-
Boston, Massachusetts
- +1 more
Nov 2, 2023